Cardiovascular health assessed by Life's Essential 8 score, genetic risk, colonoscopy status, and risk of colorectal cancer: an analysis of UK Biobank.
[OBJECTIVE] Colorectal cancer (CRC) and cardiovascular disease (CVD) share common risk factors.
- 95% CI 0.64 to 0.86
- HR 0.74
- 추적기간 12.97 years
APA
Qiu C, Wang M, et al. (2026). Cardiovascular health assessed by Life's Essential 8 score, genetic risk, colonoscopy status, and risk of colorectal cancer: an analysis of UK Biobank.. BMJ open gastroenterology, 13(1). https://doi.org/10.1136/bmjgast-2025-002010
MLA
Qiu C, et al.. "Cardiovascular health assessed by Life's Essential 8 score, genetic risk, colonoscopy status, and risk of colorectal cancer: an analysis of UK Biobank.." BMJ open gastroenterology, vol. 13, no. 1, 2026.
PMID
41850722
Abstract
[OBJECTIVE] Colorectal cancer (CRC) and cardiovascular disease (CVD) share common risk factors. This study explores the association between cardiovascular health (CVH), assessed using the Life's Essential 8 (LE8) score, and CRC risk, while examining the modifying roles of genetic predisposition and colonoscopy screening.
[METHODS] A total of 291 177 UK Biobank participants were included in the analysis. LE8 comprises eight indicators: diet, physical activity, nicotine exposure, sleep health, body mass index, blood lipids, blood glucose, and blood pressure. Cox proportional hazards models were used for analysis.
[RESULTS] During a median follow-up of 12.97 years, 3791 incident CRC cases were identified. Compared with low LE8 scores, high LE8 scores were associated with a 26% reduced CRC risk (HR: 0.74; 95% CI 0.64 to 0.86). High LE8 was linked to a 27% lower CRC risk in individuals with high genetic risk (HR: 0.73; 95% CI 0.56 to 0.94) and a 35% reduction in those without a history of colonoscopy screening (HR: 0.65; 95% CI 0.54 to 0.78). Joint analysis showed a 78% lower CRC risk in those with high LE8 and low genetic risk (HR: 0.22; 95% CI 0.15 to 0.34).
[CONCLUSION] Better CVH is associated with a reduced risk of CRC, particularly in individuals with high genetic susceptibility and those without a history of colonoscopy screening.
[METHODS] A total of 291 177 UK Biobank participants were included in the analysis. LE8 comprises eight indicators: diet, physical activity, nicotine exposure, sleep health, body mass index, blood lipids, blood glucose, and blood pressure. Cox proportional hazards models were used for analysis.
[RESULTS] During a median follow-up of 12.97 years, 3791 incident CRC cases were identified. Compared with low LE8 scores, high LE8 scores were associated with a 26% reduced CRC risk (HR: 0.74; 95% CI 0.64 to 0.86). High LE8 was linked to a 27% lower CRC risk in individuals with high genetic risk (HR: 0.73; 95% CI 0.56 to 0.94) and a 35% reduction in those without a history of colonoscopy screening (HR: 0.65; 95% CI 0.54 to 0.78). Joint analysis showed a 78% lower CRC risk in those with high LE8 and low genetic risk (HR: 0.22; 95% CI 0.15 to 0.34).
[CONCLUSION] Better CVH is associated with a reduced risk of CRC, particularly in individuals with high genetic susceptibility and those without a history of colonoscopy screening.
MeSH Terms
Humans; Male; Female; Colorectal Neoplasms; Colonoscopy; Middle Aged; United Kingdom; Genetic Predisposition to Disease; Cardiovascular Diseases; Aged; Biological Specimen Banks; Early Detection of Cancer; Risk Factors; Proportional Hazards Models; Follow-Up Studies; Adult; Risk Assessment; Body Mass Index; Exercise; Incidence; Genetic Risk Score; UK Biobank
같은 제1저자의 인용 많은 논문 (5)
- NUDT21 Drives T-Cell Acute Lymphoblastic Leukemia Through Dual Regulation of Alternative Polyadenylation and Transcriptional Activation.
- Rosmarinic acid/Se self-assembled nanoparticles for combinational therapy of triple-negative breast cancer.
- A deep learning-based automated pipeline for colorectal cancer detection in contrast-enhanced CT images.
- A panel of four autoantibodies to tumour-associated antigens in patients with prostate cancer and its potential for multi-cancer detection.
- Analysis of the Efficacy and Prognosis of Microsurgery and Transarterial Embolization in the Treatment of High-Grade Dural Arteriovenous Fistulas.